ArticleFrontiers in aging2026
Reduction of calreticulin and ERp57 with age reveals the ER stress-related roles in cell viability and organismal lifespan regulation.
Article in Frontiers in aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Defects in Calreticulin (Calr) and ER protein 57 (ERp57), two tandem endoplasmic reticulum (ER) resident proteins, are associated with pathologies ranging from protein conformational disorders to impaired immune responses but are not directly linked to aging. Methods: To address this question, we analyzed Calr and ERp57 protein levels in brain sections and liver tissues from young and old mice. To evaluate the age-related reduction of Calr and ERp57 in vivo and its physiological implications, lifespan and ER-stress assays were conducted using C. elegans strains. Subsequently, transient knockdown and overexpression of Calr and ERp57 were performed in N2a cells, followed by assessments of cell viability, protein aggregation, apoptotic pathways, and epistasis under both basal and stress conditions. Results: Here, we report that Calr and ERp57 expression is ubiquitously decreased with age in mouse tissues, and RNAi-mediated inhibition of their homologs in C. elegans leads to ER stress-related lifespan shortening. Knockdown of Calr and ERp57 in N2a cells reduces cellular viability by exacerbating protein aggregation, ER stress, and activation of pro-apoptotic pathways. In contrast, overexpression of Calr and/or ERp57 in N2a cells results in a robust increase in stress tolerance, cell viability, and suppression of apoptotic signaling pathways. Conclusion: Taken together, our findings suggest that the age-related reduction of Calr and ERp57 may serve as a potential pro-aging biomarker, contributing to the disruption of ER homeostasis and affecting cell survival and organismal lifespan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.